DePuy Synthes has petitioned the full Federal Circuit for a rehearing of a panel’s decision that revives a patent infringement lawsuit against it. The company contends that the panel’s ruling contradicts the Federal Circuit’s en banc decision in the EcoFactor case, particularly concerning the criteria for admitting expert testimony. The EcoFactor decision clarified the circumstances under which expert testimony should be allowed, and DePuy argues that this precedent was overlooked, leading to the revival of litigation it deems unwarranted. The panel’s divergence from established precedent is at the core of DePuy’s appeal for en banc review. (Law360)
The original case involves allegations of patent infringement related to DePuy’s medical devices. The recent panel decision reignites the debate over the qualifications and methodological rigor required of experts in such specialized fields. DePuy insists that upholding the panel’s decision without reconciling it with the EcoFactor precedent could lead to inconsistency and uncertainty in patent litigation. The request for a full court review aims to ensure uniformity and adherence to legal standards previously established by the Federal Circuit.
This issue underscores ongoing challenges in the judicial interpretation of expert evidence in intellectual property cases. The decision in EcoFactor was meant to provide a clearer framework, but the DePuy panel’s decision suggests ongoing difficulties in its application. As legal professionals closely watch the unfolding situation, the Federal Circuit’s response will be significant not only for DePuy but also for future patent litigation and the role of expert testimony in these high-stakes cases.